Cancer Medicine Journal Issues Research Articles in Part 2 of September 2020 Edition
September 27, 2020
September 27, 2020
MEDFORD, Massachusetts, Sept. 27 -- Cancer Medicine, a peer-reviewed journal that says it features research from biomedical researchers across the cancer sciences, published research articles, including the following topics, in Part 2 of its September 2020 edition:
CLINICAL CANCER RESEARCH:
* Testing considerations for phosphatidylinositol-3-kinase catalytic subunit alpha as an emerging biomarker in advanced breast cancer
* Exon 11 homozygous mutations and . . .
CLINICAL CANCER RESEARCH:
* Testing considerations for phosphatidylinositol-3-kinase catalytic subunit alpha as an emerging biomarker in advanced breast cancer
* Exon 11 homozygous mutations and . . .
